Tarlot 100mg Tablet

• Pancreatic cancer
• Non-small cell lung cancer

Every medicine has some side effects that typically manage on their own as your body gets used to the medicine, but some people may experience severe side effects rarely. In that case, the patient should contact the doctor immediately.

Some common side effects of Tarlot 100mg Tablet include:

• Abdominal pain
• Bone pain
• Breathlessness
• Constipation
• Cough
• Diarrhea
• Fatigue
• Fever
• Infection
• Muscle pain
• Nausea
• Rash
• Stomatitis (Inflammation of the mouth)
• Vomiting
• Weight loss

Contact your healthcare provider if you face any unusual or persistent side effects.

• The dosage and duration of the Tarlot 100mg Tablet are decided by the doctor based on the severity of the infection and other health factors. Take this tablet on an empty stomach for better results. Before starting this medicine, please inform your doctor about your medical history.
• If you experience any signs and symptoms while eating this medication that are not manageable, do not ignore those symptoms because they may lead to a higher risk.
  

• Tarlot 100mg Tablet is an anticancer medicine with Erlotinib as an active ingredient. The epidermal growth factor receptor (EGFR), a protein involved in the development and metastasis of cancer cells, is inhibited by this tablet.
• EGFR plays a crucial role in cell division, growth, and survival of unregulated cells and contributes to the spread of disease.
• This medicine inhibits EGFR activity, hence reducing or stopping the proliferation of cancer cells. It inhibits the cancer cells' signaling mechanisms.

A person should avoid smoking while undergoing treatment with Tarlot 100mg Tablet. Smoking may reduce the effectiveness of medicine in the blood.

Skin becomes extremely sensitive after taking Tarlot 100mg Tablet. So, covering your skin exposed to the sun is crucial while going out.

If you experience symptoms like blurred vision, difficulty breathing, cough & fever, and diarrhea while taking Tarlot 100mg Tablet, consult your doctor immediately before these symptoms become severe.

Tarlot 100mg Tablet should not be taken by adolescents and children under the age of 18 without a doctor's prescription.

It is advised to use effective birth control ways during the treatment with Tarlot 100mg Tablet. These trustable methods should be used for at least 2 weeks after the last dose.

• Mountzios, G., & Syrigos, K. N. (2011). A benefit-risk assessment of erlotinib in non-small-cell lung cancer and pancreatic cancer. Drug safety, 34(3), 175-186.
• Rocha-Lima, C. M., & Raez, L. E. (2009). Erlotinib (tarceva) for the treatment of non–small-cell lung cancer and pancreatic cancer. Pharmacy and Therapeutics, 34(10), 554.
• Cohen, M. H., Johnson, J. R., Chen, Y. F., Sridhara, R., & Pazdur, R. (2005). FDA drug approval summary: erlotinib (Tarceva®) tablets. The oncologist, 10(7), 461-466.
• Tsao, M. S., Sakurada, A., Cutz, J. C., Zhu, C. Q., Kamel-Reid, S., Squire, J. ... & Shepherd, F. A. (2005). Erlotinib in lung cancer—molecular and clinical predictors of outcome. New England Journal of Medicine, 353(2), 133-144.
• Fountzilas, C., Chhatrala, R., Khushalani, N., Tan, W., LeVea, C., Hutson, A. ... & Iyer, R. (2017). A phase II trial of erlotinib monotherapy in advanced pancreatic cancer as a first-or second-line agent. Cancer chemotherapy and pharmacology, 80(3), 497-505.
• Gatzemeier, U., Pluzanska, A., Szczesna, A., Kaukel, E., Roubec, J., De Rosa, F. ... & Von Pawel, J. (2007). Phase III study of erlotinib in combination with cisplatin and gemcitabine in advanced non–small-cell lung cancer: The Tarceva Lung Cancer Investigation Trial. Journal of Clinical Oncology, 25(12), 1545-1552.